During the past decade, Hospital Alvaro Cunqueiro conducted 133 clinical trials. In the 10-year time frame, 133 clinical trials started and 21 clinical trials were completed, i.e. on average, 15.8% percent of trials that started reached the finish line to date. In the past 5 years, 73 clinical trials started and 17 clinical trials were completed. i.e. 23.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Alvaro Cunqueiro" #1 sponsor was "Janssen Research & Development, LLC" with 10 trials, followed by "Spanish Breast Cancer Research Group" with 6 trials sponsored, "Shire" with 5 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Fundacin Biomedica Galicia Sur" with 4 trials sponsored. Other sponsors include 107 different institutions and companies that sponsored additional 85 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Alvaro Cunqueiro" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Apices Soluciones S.L." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Syntax for Science, S.L" with 2 trials as a collaborator. Other collaborators include 63 different institutions and companies that were collaborators in the rest 73 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Alvaro Cunqueiro" are "Coronary Artery Disease" (8 trials), "Heart Failure" (6 trials), "Ulcerative Colitis" (6 trials), "Atrial Fibrillation" (5 trials) and "Crohn's Disease" (5 trials). Many other conditions were trialed in "Hospital Alvaro Cunqueiro" in a lesser frequency.

Most popular intervention types in "Hospital Alvaro Cunqueiro" are "Drug" (75 trials), "Device" (29 trials), "Other" (19 trials), "Biological" (7 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "Ontamalimab" (4 trials), "Guselkumab" (3 trials), "Trastuzumab" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Alvaro Cunqueiro" are 129 trials for "All" genders, 9 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 64 active trials in "Hospital Alvaro Cunqueiro". 1 are not yet recruiting, 41 are recruiting, 21 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 56 completed trials in Hospital Alvaro Cunqueiro, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Alvaro Cunqueiro, 4 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 23 trials that are defined as “Not Applicable".